Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 March 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Gastric electrical stimulation for gastroparesis

October's issue of Archives of Surgery finds that gastric electrical stimulation increased body mass index, improves symptoms and gastric emptying rates, and is an alternative to gastrectomy for end-stage gastric disease.

News image

fiogf49gjkf04

Dr Rodney Mason and colleagues considered gastric electrical stimulation as an alternative to gastrectomy in patients with refractory gastroparesis.

The team conducted retrospective case series with a median follow-up of 20 months.

The researchers undertook the research in a tertiary care university hospital and a university-affiliated community hospital.

The team included 29 patients, of which 22 were women with a median age of 39 years with debilitating gastroparesis.

The patients were referred for gastrectomy from 2001 through 2004.

Body mass index improved from 23 preoperatively to 25 postoperatively
Archives of Surgery

The researchers reported that 24 patients had type 1 diabetic gastroparesis and 5 patients had idiopathic gastroparesis.

A gastric stimulator device was placed laparoscopically in 24 patients and by laparotomy in 5 patients.

The main outcome measures included morbidity and mortality of the procedure, symptom control, and hospital readmissions.

Further outcomes measured by the team were need for supplemental nutritional support, body mass index, and gastric emptying.

Follow-up results were available in 27 patients, and the team noted that there was no 30-day mortality or morbidity in 4 patients.

The median hospital stay was 3 days, and all of the patients tolerated an oral diet at discharge.

The researchers found that symptom control was excellent to good in 19 patients.

Nutritional support was discontinued in the 19 patients who were dependent on supplemental feeding before the procedure.

The research team observed that median body mass index improved significantly from 23 preoperatively to 25 postoperatively.

The median gastric emptying rate measured in 15 of 27 patients postoperatively improved from 0.2 per minute preoperatively to 0.4% per minute postoperatively.

Additional procedures were required in 4 patients, owing to poor outcome in 3 patients.

Dr Mason's team concludes, “Gastric electrical stimulation ameliorated symptoms, returned patients to normal oral nutritional intake, increased body mass index, improved gastric emptying rates, and is an alternative to gastrectomy in patients with end-stage gastric disease.”

Arch Surg 2005: 140(9): 841-8
23 September 2005

Go to top of page Email this page Email this page to a colleague

 27 March 2017 
H. pylori infection and preeclampsia
 27 March 2017 
Low-cost oral rotavirus vaccine
 27 March 2017 
 Clostridium difficile and colectomy risk in IBD
 24 March 2017 
MRI for local staging of colon cancer
 24 March 2017 
In-office communication about ulcerative colitis
 24 March 2017 
Prevalence of undiagnosed celiac disease
 23 March 2017 
Suspected nonceliac gluten sensitivity
 23 March 2017 
H. pylori and GERD in children
 23 March 2017 
Prespectives on the management of fecal incontinence
 22 March 2017 
Role of microbiota in colorectal surgery
 22 March 2017 
Disease activity in eosinophilic esophagitis
 22 March 2017 
Abdominal visceral fat and new erosive esophagitis
 21 March 2017 
Global trends in colorectal cancer mortality
 21 March 2017 
Pain in pancreatic cancer
 21 March 2017 
Hepatitis C virus–related hepatic myelopathy
 20 March 2017 
NASH treatment and MRI
 20 March 2017 
Metastasis in human colorectal cancer
 20 March 2017 
Fistula treatment of Crohn’s disease
 17 March 2017 
Microbiota in colorectal cancer 
 17 March 2017 
Among Persons with IBD
 17 March 2017 
Acute liver failure in Scotland
 16 March 2017 
Transition readiness scores in adolescents with IBD
 16 March 2017 
Hepatocellular carcinoma risk in different etiologies of cirrhosis
 16 March 2017 
IBD disability index
 15 March 2017 
European consensus on fecal microbiota transplantation 
 15 March 2017 
Hepatocellular carcinoma in the USA 
 15 March 2017 
Hospital readmission for ulcerative colitis
 14 March 2017 
Cardiovascular diseases risk in Barrett's
 14 March 2017 
Assessment of competence in colonoscopy
 14 March 2017 
Cholecystectomy to prevent recurrent pancreatitis
 13 March 2017 
Gallstone disease after colectomy for ulcerative colitis
 13 March 2017 
Achalasia in Chicago since high-resolution manometry
 13 March 2017 
Vedolizumab exposure in pregnancy
 10 March 2017 
Thiopurine therapy in IBD
 10 March 2017 
Complications in advanced fibrosis in Hep C eradication
 10 March 2017 
Intragastric balloons for obesity-related co-morbidities
 09 March 2017 
Intestinal tuberculosis vs Crohn's disease
 09 March 2017 
Predictors of relapse in children with IBD
 09 March 2017 
Direct-acting antiviral regimen for Hep C genotype 3 
 08 March 2017 
Sterile fecal filtrate transfer for C. diff
 08 March 2017 
Drug-induced liver injury
 08 March 2017 
Pharmacotherapy for alcohol dependence
 07 March 2017 
Psychotropic drugs in functional dyspepsia
 07 March 2017 
Vagus nerve and appetite regulation
 07 March 2017 
Gastrointestinal involvement in systemic sclerosis
 06 March 2017 
Small bowel abnormalities in IBS 
 06 March 2017 
Treatment response in NASH with MRI
 06 March 2017 
Intestinal bacterial overgrowth and PPIs in children
 03 March 2017 
Alcohol and risk of gallstone disease
 03 March 2017 
Smoking at colon cancer diagnosis influences survival
 03 March 2017 
Improvements in Crohn’s Disease outcomes over time
 02 March 2017 
Surviving sepsis guidelines
 02 March 2017 
Tenofovir and Hep B transmission in pregnancy
 02 March 2017 
Diagnosis of pediatric IBD 
 01 March 2017 
Healthcare utilization amonth IBD Veterans
 01 March 2017 
Complications after ileocecal resection in Crohn’s
 01 March 2017 
Fecal microbiotica transplnantation

 28 February 2017 
Smoking and cancer-specific survival in colon cancer
 28 February 2017 
ALT levels and all-cause mortality
 28 February 2017 
American Gastroenterological Association for acute liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us